These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 32694282

  • 21. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions.
    Zhang Y, Shi H, Gu Y, Xiu Y, Li B, Zhu W, Chen S, Yu H.
    Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic performance of whole-body bone scintigraphy in combination with SPECT/CT for detection of bone metastases.
    Zhang Y, Li B, Wu B, Yu H, Song J, Xiu Y, Shi H.
    Ann Nucl Med; 2020 Aug; 34(8):549-558. PubMed ID: 32583153
    [Abstract] [Full Text] [Related]

  • 23. A Prospective Study Comparing 99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with 18F-Fluoride PET/CT and 18F-Fluoride PET/MRI for Diagnosing Bone Metastases.
    Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM.
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [Abstract] [Full Text] [Related]

  • 24. Diagnostic performance of whole-body SPECT/CT in bone metastasis detection using 99mTc-labelled diphosphate: a systematic review and meta-analysis.
    Alqahtani MM, Fulton R, Constable C, Willowson KP, Kench PL.
    Clin Radiol; 2020 Dec; 75(12):961.e11-961.e24. PubMed ID: 32868091
    [Abstract] [Full Text] [Related]

  • 25. A meta-analysis of (18)F-Fluoride positron emission tomography for assessment of metastatic bone tumor.
    Tateishi U, Morita S, Taguri M, Shizukuishi K, Minamimoto R, Kawaguchi M, Murano T, Terauchi T, Inoue T, Kim EE.
    Ann Nucl Med; 2010 Aug; 24(7):523-31. PubMed ID: 20559896
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
    Dyrberg E, Larsen EL, Hendel HW, Thomsen HS.
    Acta Radiol; 2018 Sep; 59(9):1119-1125. PubMed ID: 29313360
    [Abstract] [Full Text] [Related]

  • 27. Clinical impact of targeted single-photon emission computed tomography/computed tomography (SPECT/CT) bone scintigraphy on the assessment of bone metastasis in cancer patients.
    Kapsoritakis N, Stathaki M, Bourogianni O, Tsaroucha A, Papadaki E, Simos P, Koukouraki S.
    Nucl Med Commun; 2021 Nov 01; 42(11):1202-1208. PubMed ID: 34149007
    [Abstract] [Full Text] [Related]

  • 28. Whole-Body SPECT/CT versus Planar Bone Scan with Targeted SPECT/CT for Metastatic Workup.
    Rager O, Nkoulou R, Exquis N, Garibotto V, Tabouret-Viaud C, Zaidi H, Amzalag G, Lee-Felker SA, Zilli T, Ratib O.
    Biomed Res Int; 2017 Nov 01; 2017():7039406. PubMed ID: 28812019
    [Abstract] [Full Text] [Related]

  • 29. Whole-body single photon emission computed tomography/computed tomography for assessment of oncological bone disease - is an extended field of view (from vertex to toes) of clinical value?
    Komber H, Redman S, Graham R, Anane-Adusei S, Little D.
    Nucl Med Commun; 2023 Feb 01; 44(2):131-136. PubMed ID: 36524763
    [Abstract] [Full Text] [Related]

  • 30. Protocol-driven multidetector SPECT/CT: integration of hybrid imaging into the routine workflow of whole-body bone scintigraphy in oncology patients.
    Adusumilli P, Nejadhamzeeigilani H, Pitts K, McDermott G, Scarsbrook AF, Vaidyanathan S, Patel CN, Chowdhury FU.
    Clin Radiol; 2020 Jan 01; 75(1):79.e1-79.e7. PubMed ID: 31601386
    [Abstract] [Full Text] [Related]

  • 31. Transitioning to whole-body SPECT/CT in prostate cancer staging: a new concept for a better imaging workflow.
    Weissinger M, Kupferschläger J, La Fougère C, Dittmann H, Fiz F.
    Nuklearmedizin; 2019 Dec 01; 58(6):451-459. PubMed ID: 31711243
    [Abstract] [Full Text] [Related]

  • 32. Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT.
    Liu T, Wang S, Liu H, Meng B, Zhou F, He F, Shi X, Yang H.
    J Cancer Res Clin Oncol; 2017 Mar 01; 143(3):457-465. PubMed ID: 27752772
    [Abstract] [Full Text] [Related]

  • 33. Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer.
    Chen R, Yang Q, Chen W, Yang Y, Cheng C, Sun Y, Lu J.
    World J Urol; 2021 Aug 01; 39(8):2937-2943. PubMed ID: 33521882
    [Abstract] [Full Text] [Related]

  • 34. 68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study.
    Dyrberg E, Hendel HW, Huynh THV, Klausen TW, Løgager VB, Madsen C, Pedersen EM, Pedersen M, Thomsen HS.
    Eur Radiol; 2019 Mar 01; 29(3):1221-1230. PubMed ID: 30132104
    [Abstract] [Full Text] [Related]

  • 35. Incremental value of single-photon emission computed tomography/computed tomography in the diagnosis of active condylar hyperplasia.
    Agarwal KK, Mukherjee A, St A, Tripathi M, Bal C.
    Nucl Med Commun; 2017 Jan 01; 38(1):29-34. PubMed ID: 27763953
    [Abstract] [Full Text] [Related]

  • 36. The added value of SPECT/spiral CT in patients with equivocal bony metastasis from hepatocellular carcinoma.
    Zhang Y, Shi H, Li B, Cai L, Gu Y, Xiu Y.
    Nuklearmedizin; 2015 Jan 01; 54(6):255-61. PubMed ID: 26615876
    [Abstract] [Full Text] [Related]

  • 37. 99mTc-Methylene diphosphonate SPECT/CT as the one-stop imaging modality for the diagnosis of osteoid osteoma.
    Sharma P, Mukherjee A, Karunanithi S, Nadarajah J, Gamanagatti S, Khan SA, Bal C, Kumar R.
    Nucl Med Commun; 2014 Aug 01; 35(8):876-83. PubMed ID: 24751704
    [Abstract] [Full Text] [Related]

  • 38. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
    Haraldsen A, Bluhme H, Røhl L, Pedersen EM, Jensen AB, Hansen EB, Nellemann H, Rasmussen F, Morsing A.
    Clin Physiol Funct Imaging; 2016 Jan 01; 36(1):40-6. PubMed ID: 25257661
    [Abstract] [Full Text] [Related]

  • 39. Comparison of single photon emission computed tomography-computed tomography, computed tomography, single photon emission computed tomography and planar scintigraphy for characterization of isolated skull lesions seen on bone scintigraphy in cancer patients.
    Sharma P, Jain TK, Reddy RM, Faizi NA, Bal C, Malhotra A, Kumar R.
    Indian J Nucl Med; 2014 Jan 01; 29(1):22-9. PubMed ID: 24591778
    [Abstract] [Full Text] [Related]

  • 40. Prospective comparative study of 18F-sodium fluoride PET/CT and planar bone scintigraphy for treatment response assessment of bone metastases in patients with prostate cancer.
    Fonager RF, Zacho HD, Langkilde NC, Fledelius J, Ejlersen JA, Hendel HW, Haarmark C, Moe M, Mortensen JC, Jochumsen MR, Petersen LJ.
    Acta Oncol; 2018 Aug 01; 57(8):1063-1069. PubMed ID: 29447047
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.